NEW YORK (GenomeWeb) – A multi-center trial evaluating BioMérieux's Vitek MS clinical microbiology platform has found the MALDI mass spec-based system is able to identify molds commonly tested for in patients in clinical settings with high accuracy.
Using the instrument to test 1,601 mold isolates, researchers found that 98 percent of the identifications the system provided were correct, indicating the usefulness of the platform in clinical mycology.